QOL Medical CEO Donates $75,000 to Beacon Rescue and Relief
21 Mar 2025 //
PR NEWSWIRE
FDA-Approved Sucraid Offers Free 4-Day Trial for CSID Treatment
01 Mar 2025 //
PR NEWSWIRE
QOL MEDCL`s Biologic Sucraud (Sacrosidase) Receives Suppl Approvals in US
02 Aug 2024 //
FDA
QOL Medical, LLC receives FDA approval of Sucraid
06 Sep 2022 //
PRNEWSWIRE